These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8690340)

  • 1. Insurance coverage for experimental technologies.
    Steinberg EP; Tunis S; Shapiro D
    Health Aff (Millwood); 1995; 14(4):143-58. PubMed ID: 8690340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursing new technologies: why are the courts judging experimental medicine?
    Saver RS
    Stanford Law Rev; 1992 May; 44(5):1095-131. PubMed ID: 10119850
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigational treatments: coverage, controversy, and consensus.
    Ader M
    Ann Health Law; 1996; (5):45-60. PubMed ID: 10164521
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
    Redberg RF
    Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to investigational treatments.
    Ader M
    Health Matrix Clevel; 1996; 6(1):187-99. PubMed ID: 10167167
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigational treatments. How strict should we be?
    Eddy DM
    JAMA; 1997 Jul; 278(3):179-85. PubMed ID: 9218650
    [No Abstract]   [Full Text] [Related]  

  • 8. Can surgical innovation survive? Panel presentations.
    McKneally MF; Gleeson S; Balch CM; Mussallem MA; Abel DB; Bernhard VM
    Bull Am Coll Surg; 1996 Apr; 81(4):8-21, 43. PubMed ID: 10156765
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical insurance payments and patients involved in research.
    Holder AR
    IRB; 1994; 16(1-2):19-22. PubMed ID: 11652323
    [No Abstract]   [Full Text] [Related]  

  • 11. The trouble with medical innovation.
    Moskowitz DB
    Bus Health; 1999 May; 17(5):38-42. PubMed ID: 10387675
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical technology assessment and practice guidelines: their day in court.
    Anderson GF; Hall MA; Steinberg EP
    Am J Public Health; 1993 Nov; 83(11):1635-9. PubMed ID: 8238696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging technologies and medical coverage.
    Merrikin K; Smith S
    Clin Ethics Rep; 1996; 10(1):9-12. PubMed ID: 11660222
    [No Abstract]   [Full Text] [Related]  

  • 14. Employer coverage of experimental medical procedures.
    Mora J
    Health Cost Manage; 1986; 3(5):17-25. PubMed ID: 10279242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical technology assessment--intended for whom?
    Mariner WK
    Am J Public Health; 1993 Nov; 83(11):1525-6. PubMed ID: 8238670
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory, coverage, and reimbursement changes. Implications for diffusion of technology in radiology.
    McGivney WT
    Invest Radiol; 1988 Oct; 23(10):795-8. PubMed ID: 3192402
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of health-related technologies in Germany.
    Perleth M; Busse R; Schwartz FW
    Health Policy; 1999 Jan; 46(2):105-26. PubMed ID: 10346284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The price of progress. Getting insurers to cover new procedures is often difficult.
    Borges W
    Tex Med; 2001 Jun; 97(6):56-9. PubMed ID: 11430199
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.
    Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1593-600. PubMed ID: 8047916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an alternative to a National Health Board for Technology Assessment?
    Lerner JC
    Med Interface; 1994 Jun; 7(6):123-6, 132. PubMed ID: 10135316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.